Dr. Lucian Iancovici has served as an Achieve Life Sciences director since 2026 and became Chairman of the Board effective June 8, 2026; he also serves on the Compensation Committee. He is a Partner of TPG, a global alternative asset manager, where he has worked since January 2018, and previously headed the Qualcomm Life Fund and was a general partner at dRx Capital, a Novartis-Qualcomm joint venture. Dr. Iancovici serves on the boards of Sionna Therapeutics (since 2019) and Rallybio Corporation (since 2020) and several private companies. He is a board-certified internal medicine physician who trained at Columbia University Medical Center and received his B.A. in economics and his M.D. from Tufts University.